Engineered natural killer cells for cancer therapy
Cancer Cell · 2025-11 · 43 (11) · 1987-2013
DOI: 10.1016/j.ccell.2025.09.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2025-11. Verfasst von Alexander Biederstädt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Neoplasms, Immunotherapy, Adoptive, Cell Engineering. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 357 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, Marcus Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Cell Therapy Discovery and Innovation, The University of Texas MD Anderson…
Förderung
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- Marcus Foundation
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- Cockrell Foundation
- Tanoto Foundation
- Stand up to Cancer
Zitieren
APA
Biederstädt, A., & Rezvani, K. (2025). Engineered natural killer cells for cancer therapy. Cancer Cell, 43(11), 1987-2013. https://doi.org/10.1016/j.ccell.2025.09.013
Vancouver
Biederstädt A, Rezvani K. Engineered natural killer cells for cancer therapy. Cancer Cell. 2025;43(11):1987-2013. doi:10.1016/j.ccell.2025.09.013
BibTeX
@article{Biederstdt2025,
author = {Biederstädt, Alexander and Rezvani, Katayoun},
title = {Engineered natural killer cells for cancer therapy},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {11},
pages = {1987--2013},
doi = {10.1016/j.ccell.2025.09.013}
}
EUVIMED